This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03606/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03606/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
n5http://linked.opendata.cz/resource/drugbank/drug/DB03606/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03606/identifier/pharmgkb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03606/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB03606/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03606
rdf:type
n3:Drug
n3:description
A phosphodiesterase inhibitor with antidepressant properties. [PubChem]
n3:group
experimental
owl:sameAs
n7:DB03606 n10:DB03606
dcterms:title
(S)-Rolipram
adms:identifier
n5:394978 n8:DB03606 n11:46507984 n12:4SR n13:PA153906323 n15:448055
n3:IUPAC-Name
n9:271B5824-363D-11E5-9242-09173F13E4C5
n3:InChI
n9:271B582A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n9:271B5829-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n9:271B5826-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n9:271B5827-363D-11E5-9242-09173F13E4C5
n3:SMILES
n9:271B5828-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n9:271B5822-363D-11E5-9242-09173F13E4C5
n3:logP
n9:271B5823-363D-11E5-9242-09173F13E4C5 n9:271B5820-363D-11E5-9242-09173F13E4C5
n3:logS
n9:271B5821-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n9:271B5830-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n9:271B5831-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n9:271B582B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n9:271B582C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n9:271B582E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n9:271B582D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n9:271B582F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n9:271B5836-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n9:271B5838-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n9:271B5839-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n9:271B5835-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n9:271B5834-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n9:271B5837-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n9:271B5825-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n9:271B5832-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n9:271B5833-363D-11E5-9242-09173F13E4C5